NW PharmaTech is a biotech company revolutionising the treatment of psychiatric & neurological disorders.
Our ‘Nature to Medicine’ approach involves leveraging our patented drug delivery technology to optimise naturally-derived compounds, such as cannabidiol, for therapeutic purposes.
With a solid scientific foundation and an expert team in the pharmaceutical, life sciences & cannabinoid sectors, we are bringing to market a portfolio of innovative medicines.
Our work revolves around known natural compounds with promising therapeutic properties. Our first target for drug formulation is the CBD molecule.
Our patented drug delivery technology allows us to harness the benefits of natural compounds, whilst providing a route to defensible commercialisation.
Our initial indication targets are patients at Clinical High Risk (CHR) for Psychosis and patients suffering from Insomnia Disorder, as well as other indications within the mental health complex.
We are a driven team of specialists, committed to advancing the naturally derived medicine industry. Our team has experience across multiple sectors – pharmaceutical operations, research and development, intellectual property, marketing and finance – and is based in the UK, Europe and North America.